Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. Its pipeline covers Naxitamab, Omburtamab, GD2-GD3 Vaccine, and others. Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. Its pipeline covers Naxitamab, Omburtamab, GD2-GD3 Vaccine, and others.
| Periodo † | Var | Var % | Apert. | Max | Min | Med. Vol. Giorn. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.03 | 0.613496932515 | 4.89 | 5 | 4.45 | 238765 | 4.71134609 | CS |
| 4 | -1.48 | -23.125 | 6.4 | 6.4838 | 4.25 | 339099 | 5.15367733 | CS |
| 12 | -3.13 | -38.8819875776 | 8.05 | 8.62 | 4.25 | 435045 | 6.13699163 | CS |
| 26 | -9.07 | -64.8320228735 | 13.99 | 16.11 | 4.25 | 338094 | 8.67737504 | CS |
| 52 | -9.82 | -66.6214382632 | 14.74 | 17.7775 | 4.25 | 324002 | 10.96461737 | CS |
| 156 | -7.18 | -59.3388429752 | 12.1 | 20.9 | 2.7 | 384028 | 9.10589799 | CS |
| 260 | -11.6 | -70.2179176755 | 16.52 | 55.36 | 2.7 | 349098 | 15.31411159 | CS |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Caratteristiche principali
Premium
